Physician profile
Tyler C Ford
NPI 1841449915
$5,803.06
in general payments reported to CMS, 2019-2025
32 companies · $936 in 2025
The $936 reported for 2025 was more than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $973 · 2020: $313 · 2021: $681 · 2022: $845 · 2023: $778 · 2024: $1,277 · 2025: $936.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,992.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,991.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,576.94 | 2019-2025 | Lynparza |
| Eisai INC. | $866.36 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $816.83 | 2019-2025 | Keytruda, Lynparza |
| Glaxosmithkline, LLC. | $572.28 | 2020-2025 | Jemperli, Zejula |
| Seagen INC. | $380.81 | 2021-2023 | Tivdak |
| Abbvie INC. | $325.64 | 2024-2025 | |
| Tesaro, INC. | $193.05 | 2019 | |
| Tersera Therapeutics LLC | $105.06 | 2019-2020 | |
| Clovis Oncology, INC. | $104.13 | 2019-2022 | |
| Genentech USA, INC. | $102.15 | 2019-2020 | |
| Momentis Surgical INC. | $78.00 | 2022 | |
| Pfizer INC. | $71.72 | 2024 | |
| Novartis Pharmaceuticals Corporation | $62.98 | 2024-2025 | |
| Daiichi Sankyo INC. | $58.85 | 2024-2025 | Enhertu |
| Tempus Ai, INC | $57.25 | 2024-2025 | Xt Cdx |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $50.96 | 2023-2024 | Veozah |
| Immunogen, INC. | $47.33 | 2023-2024 | Elahere, Elahere |
| Janssen Pharmaceuticals, INC | $43.50 | 2022-2023 | Xarelto |
| Davol INC. | $41.37 | 2023 | Arista Ah Flexitip |
| Verastem, INC. | $31.15 | 2025 | Avmapki Fakzynja Co-Pack |
| Teleflex LLC | $24.80 | 2025 | Quikclot |
| Sumitomo Pharma America, INC. | $23.36 | 2024 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $21.41 | 2019 | |
| Conmed Corporation | $20.22 | 2019 | |
| Array Biopharma INC | $18.71 | 2023 | Braftovi, Mektovi |
| Ipsen Biopharmaceuticals, INC | $18.26 | 2023 | Onivyde, Somatuline Depot |
| Pacira Pharmaceuticals Incorporated | $16.91 | 2019 | |
| Baxter Healthcare | $16.80 | 2025 | Perclot |
| Foundation Medicine, INC. | $16.34 | 2019 | |
| Tactile Systems Technology INC | $14.11 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $13.12 | 2022 | |
| Myovant Sciences INC. | $12.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Ford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.